Accused of terrible misjudgment in appointing Peter Mandelson as ambassador to Washington, Sir Keir Starmer says that questions were raised but answered with lies. Mandelson “portrayed Jeffrey Epstein as someone he barely knew” and was sacked as soon as it became clear the relationship had been much closer. Addressing the scale of the deception on Thursday, the prime minister sounded authentically outraged. Mandelson had failed a “basic test of honesty” and “such deceit is incompatible with public service”. Credulity is not a great defence. Focusing on the lies obscures the extent of what was already known to be true when the fateful appointment was made. It was not a secret that Mandelson had some kind of friendship with Epstein. Evidence of it was in the public domain. The necessary question that followed was what level of intimacy with a man who had trafficked underage girls for sex might be tolerable in a potential ambassador. The only good answer was zero. Downing Street failed to apply that test. One explanation is that Mandelson was deemed to possess unique qualities that made him suitable as an emissary to the court of Donald Trump. The cupidity that brought him into Epstein’s orbit in the first place, his social facility in that sleaziest of milieux, may even have been a perverse recommendation, given the character of the US president. The risk of some scandal erupting – high in any event, given Mandelson’s record of ignominious resignations dating back decades – was deemed worth taking for the perceived benefit of influence in the White House. If that was indeed the reasoning, it speaks to more than just a malfunction of political antennae. To weigh the downside of association with a convicted sex offender against an upside in diplomatic access is a calculation that would not even have occurred to people who kept care and respect for Epstein’s victims uppermost in their minds. Sir Keir has apologised to those victims, but his regret is expressed in self-ex...

peshkov The U.S. equity market ( SP500 ), ( COMP:IND ), ( DJI ) has been overvalued for an extended period, and the recent selloff in technology stocks is not entirely unexpected, according to Gregory Davis, president and CIO at Vanguard. In an interview with CNBC, Davis said the market repricing follows a “robust move” in stocks over the past year and reflects stretched valuations that have concerned the firm for some time. Davis characterized the tech rout as part of a natural market cycle, noting that certain sectors will always experience periods of boom and bust. His primary advice to investors is to maintain broad diversification across U.S. equities, international equities, bonds, and money markets rather than concentrating holdings in any single sector. When examining domestic equity valuations, Davis pointed to elevated multiples and tight implied equity risk premiums as reasons for caution. “We’ve felt that the U.S. equity market has been overvalued for some time,” he said, adding that Vanguard does not see “tremendous value” in domestic stocks at current levels. The Vanguard CIO struck a notably bullish tone on fixed income, declaring that “bonds are back.” He cited the 10-year Treasury yield ( US10Y ) at 4.20% as offering investors a meaningful premium over inflation. “This is the first time in almost a decade where you’re actually earning a real yield when it comes to investing in bonds,” Davis explained, contrasting the current environment with the near-zero rates that persisted following the global financial crisis. Given comparable return expectations for U.S. equities and bonds over the next decade, Davis suggested investors consider shifting away from the traditional 60/40 stock-bond allocation toward a 40/60 split. The rationale, he noted, is that bonds offer similar expected returns with significantly lower volatility. Addressing concerns about index concentration driven by artificial intelligence investments and the Magnificent Seven stocks—( TS...

New York Pension Funds Scrutinize Palantir Over ICE Contract Mint

The growing rift between two Gulf powers will be felt across the Middle East and the Horn of Africa In 2017, Saudi Arabia and the United Arab Emirates spearheaded a blockade of Qatar , disrupting trade, stability and lives in the region. Their de facto leaders – the Saudi crown prince, Mohammed bin Salman, and Abu Dhabi’s then crown prince, Mohamed bin Zayed Al Nahyan, now president of the UAE – had forged a close alliance . The older man had eagerly promoted the younger Saudi royal in Washington and elsewhere, and was seen as his mentor. Riyadh borrowed aspects of the UAE’s model, and the countries together intervened – at huge cost – against Houthi rebels in Yemen. Together they sought to contain the Arab spring and backed authoritarian rule in Egypt, Bahrain and elsewhere. Yet by 2023 the relationship had soured : the Saudi crown prince reportedly accused the UAE of “stabb[ing] us in the back” . Late last year the disputes became spectacularly public. In Yemen, Southern secessionists backed by the UAE made dramatic advances in oil-rich areas – before being forced out by Saudi-backed forces. Riyadh effectively described the UAE as threatening its national security . Saudi commentators voiced increasing contempt for the kingdom’s former partner. In turn, a senior Emirati official complained of “wickedness” in the media campaign against it. Continue reading...

格隆汇2月6日｜据知情人士透露，嘉能可集团在与力拓集团的谈判中，曾寻求通过股份交换使自身股东获得合并后公司约40%的股权。知情人士称，由于无法满足嘉能可提出的溢价要求，力拓退出谈判，且嘉能可拒绝调整立场。据悉，力拓此前已完成对嘉能可的尽职调查。两家公司于周四宣布终止合并谈判，该交易本将缔造全球最大矿业巨头。

Alphabet Inc_ and Google logos by IgorGolovinov via Shutterstock Alphabet (GOOG) (GOOGL) stock is sliding this morning after a slight YouTube miss and aggressive capex guidance overshadowed the company’s overall better-than-expected financials for its fiscal Q4. The post-earnings dip made GOOGL slip below its 50-day moving average (MA) today, signaling that downward momentum may sustain in the near term. Despite the recent decline, however, Google shares remain up more than 100% versus their 52-week low. Why Capex Guidance Doesn’t Warrant Selling Google Stock In its earnings release, Alphabet said its capital expenditures could soar to nearly $185 billion this year — more than double what it spent in 2025. At first glance, this headline number sure looks concerning, but a closer look reveals the company is actually spending into strength, which warrants sticking with GOOGL stock. Google Cloud brought in $17.7 billion in the fourth quarter, up a remarkable 48%, reinforcing that Alphabet isn’t just building data centers blindly, it’s responding to a massive $240 billion backlog. As Sundar Pichai, the company’s chief executive, has noted previously, “The risk of under-investing is far greater than the risk of over-investing in AI infrastructure.” Citi Reiterates GOOGL Shares as Top Pick for 2026 In a post-earnings interview with CNBC, Ron Josey, a senior Citi analyst, urged long-term investors to look past the knee-jerk reaction, reiterating Google shares as one of his top picks for 2026. According to him, Alphabet is the only tech titan with a vertically integrated artificial intelligence (AI) stack — from in-house TPU chips to the world’s most dominant consumer platforms. While the market fears the cost of artificial intelligence, Google is already seeing a 78% reduction in Gemini serving costs, Josey revealed. A 0.26% dividend yield and billions authorized for share repurchase make the AI stock even more attractive as a long-term holding. How Wall Street Recommends ...

Earnings Call Insights: SelectQuote, Inc. (SLQT) Q2 2026 Management View CEO Timothy Danker reported "a strong quarter for SelectQuote in a number of ways," highlighting successful execution during the Medicare Advantage season and a robust performance for agent productivity and profitability. Danker noted, "strong operational execution and marketing efficiency drove near-record Senior EBITDA margins of 39% on modest growth year-over-year." The Healthcare Services segment grew revenue by 26% year-over-year, with SelectRx cited as making "a significant impact in the health and quality of life for America's growing senior population." Danker announced a multiyear agreement with a key pharmacy benefit manager (PBM), stating that "SelectQuote's visibility into drug reimbursement pricing has significantly improved," which he described as "critically beneficial to our strategic priority to expand profitability." Danker also introduced a new $415 million credit facility, describing it as "an important milestone in our ability to drive consistent profitable growth." Despite reporting another strong quarter, Danker disclosed that "a recent action by a national carrier partner requires that we lower our fiscal '26 guidance." The carrier's reduction in its strategic marketing budget is expected to impact fiscal 2026 by $20 million, combined with an already expected $20 million impact from PBM reimbursement changes, leading to a total $40 million aggregate impact on guidance. CFO Ryan Clement stated, "SelectQuote had a very strong quarter with revenue growth of 12% year-over-year, totaling $537 million." Clement also highlighted, "Senior revenue of $262 million grew 2% on increased approved policy volumes," and emphasized that the PBM headwind was "offset by Senior margins near record levels at 39%." Outlook Updated fiscal 2026 guidance reflects a reduction due to PBM and carrier impacts. Clement detailed, "we are revising our fiscal 2026 consolidated revenue range to $1.61 bil...

Anthropic法律服务工具引发的软件股大跌尚未平息 ， 该公司 周四又发布了其最强人工智能（AI）模型的新版本，主要用于执行金融研究。 该公司称，这款名为Claude Opus 4.6的版本能够检视企业数据、监管备案文件和市场信息，并生成详细的金融分析报告，通常这类工作通常需要人工耗时数天才能完成。此外，Opus 4.6还将提升一系列其他办公功能，包括制作电子表格和演示文稿，以及软件开发。 该消息发布后，金融服务公司股价应声下跌， FactSet Research Systems Inc．跌幅一度高达10% ，标普全球、穆迪和 纳斯达克 股价也均大幅走低。 Anthropic及其竞争对手OpenAI过去一年中的大部分时间里都在开发人工智能工具，试图简化包括金融服务、医疗保健在内多个专业领域的任务，目标是吸引更多企业客户并为自身高昂的估值提供合理依据。目前，Anthropic正在洽谈按照3，500亿美元的估值进行新一轮融资，而OpenAI正在进行的融资谈判对公司估值高达8，300亿美元。 OpenAI还推出了AI编程助手Codex的更新版本，旨在进一步简化代码编写和调试流程，并可用于构建复杂的视频游戏和应用程序等软件。该公司强调，这一产品的功能已从编写软件延伸至一系列相关文档和演示工作，例如协助制作幻灯片和分析用户数据。 Anthropic拥有超过30万家企业客户，这些客户利用其模型来辅助一些工作任务，特别是在计算机编程领域。凭借Claude Code，Anthropic已成为该市场的领导者。 这种向编程以外领域的扩张近来令华尔街感到不安。Anthropic此前低调发布的一款自动化法律服务工具在本周引发软件股暴跌，投资者担心一些软件最终会被淘汰。 Anthropic的Claude模型产品负责人表示，公司计划重点提升在 网络安全、生命科学、医疗保健和金融服务 等相关领域的执行能力。 “ 这些是我们将会全力投入的领域 ，”他说道。 责任编辑：李桐

Getty Images Introduction & Financials PDD Holdings Inc. ( PDD ) fell significantly in recent months, which I believe offers an opportunity to get one of China’s strongest balance sheets at a significant discount, with strong recovery potential, while the market focuses on broader macro headwinds. PDD Holdings IR We saw PDD’s Q3 report miss the market's revenue estimates by beating on EPS significantly, with the revenue being split almost perfectly between online marketing services and transaction services, while their cost of revenues rose by nearly 26% over the 9M period, and sales and marketing ones increased by ~13.76%. However, this caused the stock to drop on the day of the release, with the company's management saying during their Q3 Earnings Release that their revenue growth continued to moderate, which comes as a result of the “ongoing evolution of the competitive landscape and external uncertainties,” - which the market never likes. PDD Holdings IR PDD Holdings IR Financially, based on PDD’s latest report, we see an exceptional position, with the current assets covering their total liabilities. Meanwhile, the company reached roughly $68 billion in net cash (including cash and cash equivalents, restricted cash and short-term investments), generating $3.43 billion worth of interest income over the past 12 months, which isn't an uncommon position for a Chinese company, but I'll highlight that we're talking about the best net cash position among the Chinese giants like Alibaba Group Holding Limited ( BABA ), Tencent Holdings Limited ( TCEHY ) or JD.com, Inc. ( JD ), as well as the best margins - which is very impressive. Despite this exceptional position, the company still doesn’t do dividends or buybacks - unlike their Chinese peers - focusing more on investing in their ecosystem, and I’d personally rather see that instead of a 1-2% dividend and a few buybacks - unless the stock gets very cheap. Risks & Opportunities Statista (ECDB) As we can see, the US is b...

Earnings Call Insights: Peabody Energy Corporation (BTU) Q4 2025 Management View CEO Jim Grech opened the call highlighting a record safety year with a 0.71 incident rate per 200,000 hours, a 12% improvement over the previous record, and noted "Operationally and financially, the quarter was right down the fairway and meeting or surpassing expectations across key metrics." Grech announced the Centurion mine is starting longwall mining ahead of schedule, describing it as "the cornerstone asset in our strategy to maximize long-term shareholder value and to intentionally reweight our portfolio toward higher-margin metallurgical coal." He outlined Centurion's expected shipment of 3.5 million tons in 2026, ramping to 4.7 million by 2028, and projected an NPV of $2.1 billion at $225 benchmark pricing. Grech detailed ongoing asset optimization and development activities, including rare earth and critical mineral testing at U.S. mines and an options-based approach to accelerate time to market for rare earths. He stated, "We are sufficiently encouraged to continue our progress here to further evaluate the commercial potential." The CEO also noted his appointment as chair of the National Coal Council, emphasizing Peabody’s role in shaping U.S. energy policy and advocating for coal’s continued centrality in the energy mix. Malcolm Roberts, Executive VP & Chief Commercial Officer, reported "benchmark pricing has risen to its highest mark in 18 months and increased 15% from $190 per tonne levels of the beginning of the fourth quarter," with further 15% increases since year start. He pointed to tightening global metallurgical coal markets, supply constraints in China and India, and stable thermal coal markets with Newcastle prices at $115 per tonne. CFO Mark Spurbeck stated, "In the fourth quarter, we reported net income attributable to common stockholders of $10.4 million or $0.09 per diluted share and adjusted EBITDA of $118 million, a 19% increase from the prior quarter, suppor...

Earnings Call Insights: RBC Bearings (RBC) Q3 2026 Management View CEO Mike Hartnett reported third quarter net sales of $461 million, a 17% increase over last year, driven by strong performance in the Aerospace & Defense (A&D) segment and industrial business growth. He stated, "Total A&D sales were up 41.5% year-on-year. Commercial aerospace expanded 21.5%, defense expansion was 86.2%." Hartnett further highlighted that the company "modestly exceeded our $2 billion backlog mark" and described the outlook on the A&D sector as "extremely robust," noting that the company is at a "national inflection point in the commercial Aircraft and Defense industries." Hartnett detailed multiple growth drivers, including accelerated submarine fleet build-out, strong missile and guided arms demand, NATO's 5% GDP initiative fueling European demand, and increased refurbishment and new construction of aircraft systems in the U.S. He emphasized, "We are working diligently to add machinery and staff to several of our existing sites, guided by our 5-year per site plan to support these growing A&D revenues." In the industrial segment, overall business was up 3.1%, with particular strength in aggregates, cement, food and beverage, and warehousing. Hartnett pointed out, "The semiconductor industry is the biggest standout in this regard," and announced the introduction of several new products for FY '27 and a new Midwest service center. CFO Robert Sullivan stated, "Net sales grew 17%, which led to a 16.9% increase in our reported gross margin. Gross margins were 44.3% for the quarter or 45.1% on an adjusted basis compared to 44.3% in the same period last year." Sullivan highlighted free cash flow of $99.1 million and an adjusted diluted EPS of $3.04, representing 29.9% year-over-year growth. He also noted, "We paid off $81 million of debt during the quarter and another $67 million since the end of the third quarter." Outlook Sullivan provided fourth quarter guidance: "We are guiding revenues...

Eduardo Monroy Husillos/iStock via Getty Images Shares of Eli Lilly ( LLY ) and Novo Nordisk ( NVO ) came under pressure on Thursday. Hims & Hers Health ( HIMS ) announced a low-cost compounded version of the Danish drugmaker’s newly launched oral obesity therapy, the Wegovy pill. Novo ( NVO ) dropped ~8%, extending a recent sell-off that followed an underwhelming sales outlook issued earlier this week. Eli Lilly ( LLY ), which is awaiting the U.S. launch of its oral weight loss therapy, Orforglipron, in Q2, slipped ~7%, reversing gains made on Wednesday on the back of a strong Q4 2025 earnings report. HIMS said its copycat version will be launched at an introductory price of $49 per month, indicating a roughly $100 discount to Novo’s ( NONOF ) brand-name product, which entered the U.S. market in January, drawing strong demand. The telehealth platform added that its GLP-1 pill will be customizable to treat patients who are seeking to manage their side effects and those who are averse to needles. Gaston Kroub, a patent lawyer in New York, told Reuters that by customizing its product for those patients, Hims & Hers ( HIMS ) is touting its treatment as another personalized option, broadening the bounds of personalization under the FDA’s framework. However, Novo ( NVO ) called the action “illegal mass compounding” that significantly impacts patient safety and added it will resort to legal and regulatory measures “to protect patients, our intellectual property, and the integrity of the US gold-standard drug approval framework.” "HIMS has shown a willingness to go as close to the line as possible," Kroub said, adding, “It’s a strategy of saying, ‘All right, if we pop our head over the barbed wire fence, is anybody going to take a shot?’” More on Eli Lilly, Novo Nordisk, etc. Eli Lilly and Company 2025 Q4 - Results - Earnings Call Presentation Novo Nordisk A/S (NOVO:CA) Q4 2025 Earnings Call Transcript Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript CVS Health...

罗素2000指数最新下跌1.5%，跌至近一个月低点。 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

格隆汇2月6日｜罗素2000指数跌至近一个月低点，最新下跌1.5%。

US equity indexes slumped in midday trading on Thursday as weak labor market reports sent government Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.

Getty Images It has been a long time since I covered shares of Medtronic plc ( MDT ) , for that, we have to go back to the summer of 2020 when I believed that the situation was improving following a mega-deal for Covidien a few years before. Shares have seen dismal returns ever since, like many of its peers. Meanwhile, the business has found itself on a more stable footing, posting more impressive growth after a tough decade. Modest growth and flattish share price performance make for a valuation multiple that gradually has come down to the point at which appeal is in sight, although valuations across the sector have been pressured by GLP-1 drugs, among others. With appeal increasing, the upcoming decade is expected to be better than the past, although that is not a high hurdle, of course. Diversified MedTech Medtronic is a diversified medtech player, in fact, quite a large one, which generates about $33 billion in sales. These revenues are generated across four divisions, although the business relies on the three largest segments. The largest of these is a $12.5 billion cardiovascular business, complemented by a $9.8 billion neuroscience business and an $8.4 billion medical surgical segment. The fourth segment is much smaller, this being a $2.8 billion diabetes business, which the company aims to divest. The issue is that the business has seen real stagnation after the announcement of a massive, near $43 billion deal to acquire Covidien in 2014. Following that purchase, revenues grew to $29 billion in 2016, and frankly, only modest inroads have been seen, with revenues having advanced to $33 billion in 2025, as growth did not keep up with inflation. The company has managed to buy back about 10% of its shares over this period of time, albeit that investors have been paid sound dividends over time, with the dividend yield approaching 3% here. When I looked at the results in 2020, earnings were seen coming in around a roughly 20 times earnings multiple, looking quite ...

This article first appeared on GuruFocus. Broadcom (AVGO) climbed about 4% on Thursday morning after Alphabet (NASDAQ:GOOGL) said it would lift capital spending to roughly $175 billion to $185 billion, a move that investors see as a major tailwind for custom AI chips and networking gear. Jefferies kept a Buy rating and put a $500 price target on Broadcom, saying the firm could capture a dominant share of Google's custom chip orders, roughly 85%90% of an estimated six million units in calendar 2027, which supports upside for AVGO, the bank wrote. Analysts point to Broadcom's strength across ASICs and networking, including ramps in next-generation switches and DSP gains that could outpace other segments this quarter. Wolfe and other shops have issued bullish notes in recent sessions. TV commentator Jim Cramer called Broadcom a winner in this environment, though he suggested waiting for a pullback before entering. Market watchers also flagged a recent senior-notes offering and insider activity as items to monitor. Nvidia (NVDA) and memory suppliers also rose on the news, underscoring a sector rotation into AI infrastructure plays as investors parse capex winners and losers.

MicroStockHub/iStock via Getty Images Written by Nick Ackerman MSC Income Fund ( MSIF ) is a business development company that hit the public market on January 29, 2025. However, the actual inception of the fund goes back to November 1, 2011. While the public track record is relatively short-lived, they have the strong name recognition of being a wholly owned subsidiary of Main Street Capital Corporation ( MAIN ). That has been the case since October 2020, when they took over as sole adviser, and prior to that, the MAIN team was a sub-adviser to the fund. Suffice it to say, anyone even only partially familiar with BDCs is likely to recognize MAIN as one of the best. We'll be digging into MSIF today, but also making a number of comparisons with MAIN to help get a better overall understanding of this BDC's operations. All that said, with insider ownership to help with shareholder alignment and the BDC trading at an attractive discount, this is a name worth considering. That is, even with its relatively short public track record. MSIF Basics 1-Year Z-score: -1.51 Discount/Premium: -19.56% Dividend Yield: 10.54% Debt to NAV: 0.7x Managed Assets: $1.5 billion MSIF is a "BDC that provides capital to private U.S. companies," which has been "externally managed by a wholly owned subsidiary of Main Street Capital Corp since October 2020." MSIF is a relatively smaller BDC with around $1.5 billion in total assets compared to MAIN at ~$8.7 billion. The investment objective is "primarily to generate current income through debt investments and secondarily to generate current income and long-term capital appreciation through equity and equity-related investments." Internal Vs. External Management Shareholder Alignment Brings Potential Issues In looking at the structure of the BDC, there is a difference. MAIN is internally managed, and MSIF is then externally managed by the same team. That takes away one of the advantages, which is often lower expenses and shareholder alignment. The...

da-kuk/E+ via Getty Images By Elior Manier Risk assets are not enjoying their 2026 resolutions. Kevin Warsh’s impact on markets remains unclear, but the immediate price action since his nomination has been far from reassuring. For clarity, he will only officially become the next Fed Chair after Senate confirmation. Equity indexes had already been flashing warning signs, with a persistent and sharp divergence between heavy outflows from Tech and Semiconductors - despite record earnings - and inflows into more defensive sectors. Per sector performance in stocks - February 5, 2026 (Source: TradingView) What stood out in today’s session is that even dovish data failed to lift sentiment (compared to how markets reacted to them in 2025). This morning’s releases showed a sharp drop in job openings (JOLTS at 6.542M vs. 7.2M expected), while layoffs surged at the highest pace for January since 2009, according to the latest Challenger report. Markets will get more clarity next week with the delayed Non-Farm Payrolls release (Wednesday at 8:30 a.m.), but until then, uncertainty dominates. Challenger Job Cuts - January 2026 report (Source: Challenger, Grey and Christmas) What appears to be weighing most on markets is a broad deleveraging from extreme debasement trades that became heavily one-sided throughout 2025. Bitcoin is now trading below $70,000 (more on this later today), and metals are also under pressure. As profits are taken and stop-losses are triggered, price moves can become exaggerated. Looking at current flows and higher-time frame charts, this selloff still looks like a profit-taking phase - suggesting there may be more to come. In that aspect, let's dive into a higher time frame analysis and key trading levels for the major US indices: the Dow Jones ( DJI ) and Nasdaq ( NDX ). Current picture for the Stock Market (11:47 A.M. ET) - February 5, 2026 (Source: TradingView) The picture is not a good-looking one. Selloffs are widespread across the board and aren't sol...

Tesla's robotaxi business has immense potential, but Tesla also trades at a high valuation. While Tesla (TSLA 1.98%) remains a battleground stock on Wall Street, one analyst is growing increasingly optimistic about the company's burgeoning robotaxi fleet. Wolfe Research analyst Emmanuel Rosner recently issued a research note, calling 2026 a potentially "catalyst-rich year" for Tesla. Rosner said his model projects robotaxi revenue growing to $250 billion by 2035, assuming 30% autonomous vehicle penetration, Tesla gobbling up 50% market share, and a $1-per-mile model input. This would support a $2.75 trillion equity value, which would be about $900 billion when discounted back to the present and equal $250 per share for the unit "Optimus and FSD (full self-driving) licensing would support even additional upside," Rosner added. While the note is optimistic on robotaxis, here are two things to know. Understanding Tesla's current position and valuation Rosner splashed some cold water on Tesla stock later in his note. The analyst expects Tesla to incur high costs to build out the robotaxi fleet and the Optimus humanoid robots. This will likely have an adverse impact on the company's earnings in the near term. Rosner expects Tesla to launch robotaxis in seven new markets in the first half of this year, and that losses from the robotaxi business will mount to $500 million, as the company grows its fleet from about 250 vehicles to 7,200. "... While we have concerns on near-term earnings, we remain tactically constructive, with a steady stream of catalysts ahead," Rosner wrote. Expand NASDAQ : TSLA Tesla Today's Change ( -1.98 %) $ -8.04 Current Price $ 397.97 Key Data Points Market Cap $1.4T Day's Range $ 387.55 - $ 402.02 52wk Range $ 214.25 - $ 498.83 Volume 2M Avg Vol 74M Gross Margin 18.03 % Another thing investors should understand is that the company already has a $1.25 trillion market cap, despite its core electric vehicle business struggling in a difficult EV market...

格隆汇2月6日｜中国地震台网正式测定：02月06日02时06分在印尼爪哇岛南部海域（南纬8.95度，东经111.05度）发生5.7级地震，震源深度50千米。

大陸動力電池紅鏈 市占逾七成 寧德時代2025年再度稱霸全球 | 大陸政經 | 兩岸 經濟日報

大陸動力電池紅鏈 市占逾七成 寧德時代2025年再度稱霸全球 經濟日報

大陸動力電池紅鏈市占逾七成 寧德時代2025年再度稱霸全球 聯合新聞網

In trading on Thursday, shares of the SPDR Portfolio TIPS ETF (Symbol: SPIP) crossed above their 200 day moving average of $25.58, changing hands as high as $25.84 per share. SPDR Portfolio TIPS shares are currently trading up about 1.1% on the day. The chart below shows the one year performance of SPIP shares, versus its 200 day moving average: Looking at the chart above, SPIP's low point in its 52 week range is $24.331 per share, with $26.74 as the 52 week high point — that compares with a last trade of $25.80. Click here to find out which 9 other ETFs recently crossed above their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Investors in Bloom Energy Corp (Symbol: BE) saw new options become available today, for the March 27th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the BE options chain for the new March 27th contracts and identified one put and one call contract of particular interest. The put contract at the $128.00 strike price has a current bid of $17.70. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $128.00, but will also collect the premium, putting the cost basis of the shares at $110.30 (before broker commissions). To an investor already interested in purchasing shares of BE, that could represent an attractive alternative to paying $134.13/share today. Because the $128.00 strike represents an approximate 5% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 70%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 13.83% return on the cash commitment, or 101.03% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Bloom Energy Corp, and highlighting in green where the $128.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $145.00 strike price has a current bid of $28.35. If an investor was to purchase shares of BE stock at the current price level of $134.13/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $145.00. Considering the call sel...

Investors in Hilton Worldwide Holdings Inc (Symbol: HLT) saw new options begin trading today, for the March 27th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the HLT options chain for the new March 27th contracts and identified one put and one call contract of particular interest. The put contract at the $305.00 strike price has a current bid of $7.80. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $305.00, but will also collect the premium, putting the cost basis of the shares at $297.20 (before broker commissions). To an investor already interested in purchasing shares of HLT, that could represent an attractive alternative to paying $307.36/share today. Because the $305.00 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 58%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 2.56% return on the cash commitment, or 18.68% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Hilton Worldwide Holdings Inc, and highlighting in green where the $305.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $310.00 strike price has a current bid of $10.00. If an investor was to purchase shares of HLT stock at the current price level of $307.36/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $310.00. Co...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the iShares J.P. Morgan USD Emerging Markets Bond ETF (Symbol: EMB) where we have detected an approximate $289.5 million dollar outflow -- that's a 2.3% decrease week over week (from 140,700,000 to 137,500,000). The chart below shows the one year price performance of EMB, versus its 200 day moving average: Looking at the chart above, EMB's low point in its 52 week range is $84.78 per share, with $93.97 as the 52 week high point — that compares with a last trade of $90.31. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ». Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs. Click here to find out which 9 other ETFs experienced notable outflows » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the March 27th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the ABBV options chain for the new March 27th contracts and identified one put and one call contract of particular interest. The put contract at the $190.00 strike price has a current bid of $1.20. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $190.00, but will also collect the premium, putting the cost basis of the shares at $188.80 (before broker commissions). To an investor already interested in purchasing shares of ABBV, that could represent an attractive alternative to paying $216.85/share today. Because the $190.00 strike represents an approximate 12% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 85%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 0.63% return on the cash commitment, or 4.61% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for AbbVie Inc, and highlighting in green where the $190.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $220.00 strike price has a current bid of $6.45. If an investor was to purchase shares of ABBV stock at the current price level of $216.85/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $220.00. Considering the call seller will a...

Investors in Chemours Co (Symbol: CC) saw new options become available today, for the March 27th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the CC options chain for the new March 27th contracts and identified the following call contract of particular interest. The call contract at the $18.00 strike price has a current bid of 5 cents. If an investor was to purchase shares of CC stock at the current price level of $17.11/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $18.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 5.49% if the stock gets called away at the March 27th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CC shares really soar, which is why looking at the trailing twelve month trading history for Chemours Co, as well as studying the business fundamentals becomes important. Below is a chart showing CC's trailing twelve month trading history, with the $18.00 strike highlighted in red: Considering the fact that the $18.00 strike represents an approximate 5% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 47%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 0.29% boost of extra return to the investo...